Chugai Pharmaceutical : Double-digit revenue and profit growth driven by strong sales and robust pipeline progress
Revenue and profits saw double-digit growth year-over-year, driven by robust domestic and overseas sales, increased royalty and one-time income, and strong performance in oncology and specialty products. The company maintained high free cash flow and equity ratios, with a positive outlook for the f…